A novel mRNA cancer vaccine helps cut the chances of melanoma tumor recurrence in major study
CBC - Oct 23, 2026
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients' tumors come back, according to results of a major study released Thursday by drugmakers Moderna and Merck.
Spearheaded by the industry’s most influential trendsetters, UptownStars promise you 24/7 of the juiciest, trendiest, glamorous and chic trends in the e-tertainment culture.